Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
[Microglia in pathophysiology of neuroimmunological disorders].
Management of fingolimod-associated macular edema.
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis.
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
Pregnancy, sex and hormonal factors in multiple sclerosis.
Immunotherapy of Neuromyelitis Optica.
Impaired adult myelination in the prefrontal cortex of socially isolated mice.
Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.
Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regeneration.
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography.
[Optical coherence tomography in neuro-ophthalmology].
Imaging resting state brain function in multiple sclerosis.
Glial progenitor cell-based treatment and modeling of neurological disease.
Acute demyelinating encephalomyelitis in a child following malaria.
The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies.
Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
Revisiting the management of fatigue in multiple sclerosis in the context of rehabilitation: a narrative review of current evidence.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis (commentary).
[Autonomic neuropathies].
Can HPV immunisation cause ADEM? Two case reports and literature review.
Leukoencephalopathy due to Oral Methotrexate.
Neuregulin and BDNF Induce a Switch to NMDA Receptor-Dependent Myelination by Oligodendrocytes.
Pages
« first
‹ previous
…
344
345
346
347
348
349
350
351
352
…
next ›
last »